Biogen Idec CEO James Mullen - CEO pay report

Biogen Idec CEO James Mullen

James Mullen - Biogen Idec

Total Compensation: $8.9 million

Details: Mullen garnered $1.14 million in base salary, $1.94 million in incentives and $159,625 in other compensation. Most of Mullen's earnings this year came from $7.23 million in stock. Despie the big numbers, Mullen earned almost a third less in 2007 than he did in 2006, primairly due to Biogen Idec's failed bid to find a buyer for the company.

Biogen Idec News:
Biogen squares off against Icahn
Icahn aims for Biogen control
Biogen CEO: Pharma too wimpy to deal
Biogen shares deflate as it gives up on sale
Biogen Idec in play after Icahn makes his move

Biogen Idec CEO James Mullen - CEO pay report
Read more on

Suggested Articles

Horizon Therapeutics is expanding its U.S. footprint to the Bay Area—the company unveiled a new R&D and manufacturing site in South San Francisco.

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.

Biogen’s Al Sandrock has given a bullish assessment of Alzheimer’s disease drug aducanumab. The head of R&D at Biogen thinks the drug works, despite i